Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1,Condition 2,Condition 3 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000364,F344/NSlc,male,210 days,22,,CMO:0000046,blood glucose level,,,,87,mg/dl,1.2,5.6285,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,0,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13206,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ", 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000364,F344/NSlc,male,210 days,22,,CMO:0000046,blood glucose level,,,,105.6,mg/dl,1.5,7.0356,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,30,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13207,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ", 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000364,F344/NSlc,male,210 days,22,,CMO:0000046,blood glucose level,,,,112,mg/dl,2.2,10.3189,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,60,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13208,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ", 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000364,F344/NSlc,male,210 days,22,,CMO:0000046,blood glucose level,,,,106,mg/dl,2.0,9.3808,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,90,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13209,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ", 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000364,F344/NSlc,male,210 days,22,,CMO:0000046,blood glucose level,,,,107.3,mg/dl,2.0,9.3808,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,120,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13210,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ", 106,"Fuse M, et al., Physiol Genomics. 2008 Jul 8;.",blood glucose amount,,RS:0000364,F344/NSlc,male,420 days,7,,CMO:0000046,blood glucose level,,,,99,mg/dl,4.48,11.853,MMO:0000113,oral glucose tolerance test,,0,,oral dose,0,min,specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) ,13156,specific pathogen-free condition,fasting (for 16 hours),glucose solution (2 g/kg) 106,"Fuse M, et al., Physiol Genomics. 2008 Jul 8;.",blood glucose amount,,RS:0000364,F344/NSlc,male,420 days,7,,CMO:0000046,blood glucose level,,,,134.1,mg/dl,4.7,12.435,MMO:0000113,oral glucose tolerance test,,0,,oral dose,15,min,specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) ,13157,specific pathogen-free condition,fasting (for 16 hours),glucose solution (2 g/kg) 106,"Fuse M, et al., Physiol Genomics. 2008 Jul 8;.",blood glucose amount,,RS:0000364,F344/NSlc,male,420 days,7,,CMO:0000046,blood glucose level,,,,149.1,mg/dl,4.2,11.1122,MMO:0000113,oral glucose tolerance test,,0,,oral dose,30,min,specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) ,13158,specific pathogen-free condition,fasting (for 16 hours),glucose solution (2 g/kg) 106,"Fuse M, et al., Physiol Genomics. 2008 Jul 8;.",blood glucose amount,,RS:0000364,F344/NSlc,male,420 days,7,,CMO:0000046,blood glucose level,,,,157,mg/dl,5.21,13.7844,MMO:0000113,oral glucose tolerance test,,0,,oral dose,60,min,specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) ,13159,specific pathogen-free condition,fasting (for 16 hours),glucose solution (2 g/kg) 106,"Fuse M, et al., Physiol Genomics. 2008 Jul 8;.",blood glucose amount,,RS:0000364,F344/NSlc,male,420 days,7,,CMO:0000046,blood glucose level,,,,149,mg/dl,3.52,9.313,MMO:0000113,oral glucose tolerance test,,0,,oral dose,120,min,specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) ,13160,specific pathogen-free condition,fasting (for 16 hours),glucose solution (2 g/kg) 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood glucose amount,,RS:0000364,F344/NSlc,male,211 days,7,,CMO:0000046,blood glucose level,,,,78,mg/dl,2.6,6.879,MMO:0000113,oral glucose tolerance test,,0,"ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN)",oral glucose,0,min,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",12770,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) "